Fig. 1
From: Dental pulp stem cells used to deliver the anticancer drug paclitaxel
Viability assay results on control and drug-treated cells. Dental pulp and bone marrow mesenchymal stem cells incubated for 12 h with and without paclitaxel at 10 μM concentration. MCF-7 cells tested as positive control. Comparing treated DPSCs and BM-MSCs, viability measurements of test samples showed significant difference (***p < 0.001). Histogram reports mean cellular viability (%) measurement ± SD of three independent experiments. PTX paclitaxel, DPSC dental pulp stem cell, BM-MSC bone marrow-derived mesenchymal stem cell, MCF-7 Michigan Cancer Foundation-7